DE602004009200D1 - Tetrahydrochinazolinderivate als cfr-antagonisten - Google Patents

Tetrahydrochinazolinderivate als cfr-antagonisten

Info

Publication number
DE602004009200D1
DE602004009200D1 DE602004009200T DE602004009200T DE602004009200D1 DE 602004009200 D1 DE602004009200 D1 DE 602004009200D1 DE 602004009200 T DE602004009200 T DE 602004009200T DE 602004009200 T DE602004009200 T DE 602004009200T DE 602004009200 D1 DE602004009200 D1 DE 602004009200D1
Authority
DE
Germany
Prior art keywords
sup
tetrahydrochinazoline
derivatives
cfr
antagonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004009200T
Other languages
English (en)
Other versions
DE602004009200T2 (de
Inventor
Robin Douglas Clark
Richard Leo Cournoyer
Counde O'yang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE602004009200D1 publication Critical patent/DE602004009200D1/de
Application granted granted Critical
Publication of DE602004009200T2 publication Critical patent/DE602004009200T2/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/94—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DE602004009200T 2003-08-12 2004-08-03 Tetrahydrochinazolinderivate als cfr-antagonisten Active DE602004009200T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49451103P 2003-08-12 2003-08-12
US494511P 2003-08-12
PCT/EP2004/008661 WO2005014557A1 (en) 2003-08-12 2004-08-03 Tetrahydroquinazoline derivatives as cfr antagonists

Publications (2)

Publication Number Publication Date
DE602004009200D1 true DE602004009200D1 (de) 2007-11-08
DE602004009200T2 DE602004009200T2 (de) 2008-07-10

Family

ID=34135343

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004009200T Active DE602004009200T2 (de) 2003-08-12 2004-08-03 Tetrahydrochinazolinderivate als cfr-antagonisten

Country Status (9)

Country Link
US (1) US7223767B2 (de)
EP (1) EP1656354B1 (de)
JP (1) JP2007501821A (de)
CN (1) CN100398524C (de)
AT (1) ATE374190T1 (de)
CA (1) CA2534785A1 (de)
DE (1) DE602004009200T2 (de)
ES (1) ES2293317T3 (de)
WO (1) WO2005014557A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0525068D0 (en) 2005-12-08 2006-01-18 Novartis Ag Organic compounds
WO2008006039A1 (en) 2006-07-06 2008-01-10 Array Biopharma Inc. Dihydrothieno pyrimidines as akt protein kinase inhibitors
US8063050B2 (en) 2006-07-06 2011-11-22 Array Biopharma Inc. Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
DE602007011628D1 (de) 2006-07-06 2011-02-10 Array Biopharma Inc Dihydrofuropyrimidine als akt-proteinkinaseinhibitoren
UA99597C2 (ru) * 2006-07-06 2012-09-10 Еррей Біофарма Інк. Пиримидилциклопентаны как ингибиторы акт протеинкиназ
US9409886B2 (en) 2007-07-05 2016-08-09 Array Biopharma Inc. Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
US8846683B2 (en) 2007-07-05 2014-09-30 Array Biopharma, Inc. Pyrimidyl cyclopentanes as Akt protein kinase inhibitors
EP2173723B3 (de) * 2007-07-05 2014-11-19 Array Biopharma Inc. Pyrimidylcyclopentane als inhibitoren der akt-proteinkinase
CA2692502C (en) 2007-07-05 2016-03-01 Array Biopharma Inc. Pyrimidyl cyclopentanes as akt protein kinase inhibitors
KR101624752B1 (ko) * 2008-01-09 2016-05-26 어레이 바이오파마 인크. Ａｋｔ 단백질 키나제 저해물질로써의 수산화된 피리미딜 시클로펜탄
WO2009089459A1 (en) * 2008-01-09 2009-07-16 Array Biopharma Inc. Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors
US8741259B2 (en) * 2008-10-20 2014-06-03 Marvin C. Gershengorn Low molecular weight thyroid stimulating hormone receptor (TSHR) agonists
US8349852B2 (en) 2009-01-13 2013-01-08 Novartis Ag Quinazolinone derivatives useful as vanilloid antagonists
JP2013518085A (ja) 2010-02-01 2013-05-20 ノバルティス アーゲー ＣＲＦ−１受容体アンタゴニストとしてのピラゾロ［５，１ｂ］オキサゾール誘導体
WO2011092293A2 (en) 2010-02-01 2011-08-04 Novartis Ag Cyclohexyl amide derivatives as crf receptor antagonists
EP2531490B1 (de) 2010-02-02 2014-10-15 Novartis AG Cyclohexylamidderivate als crf-rezeptorantagonisten
CA2789818A1 (en) 2010-04-08 2011-10-13 The United States Of America, As Represented By The Secretary, Departmen T Of Health And Human Services Inverse agonists and neutral antagonists for the tsh receptor
CA2844699C (en) 2011-04-01 2019-05-07 Genentech, Inc. Combinations of akt inhibitor compounds and abiraterone, and methods of use
TR201815685T4 (tr) 2011-04-01 2018-11-21 Genentech Inc Kanser tedavisi için akt ve mek inhibe edici bileşiklerin kombinasyonları.
UY34094A (es) 2011-05-27 2013-01-03 Novartis Ag Derivados de la piperidina 3-espirocíclica como agonistas de receptores de la ghrelina
EA201491990A1 (ru) 2012-05-03 2015-02-27 Новартис Аг L-малатная соль 2,7-диазаспиро[4.5]дец-7-иловых производных и их кристаллические формы в качестве агонистов грелиновых рецепторов
AU2013309868A1 (en) 2012-08-30 2015-03-12 Nippon Shinyaku Co., Ltd. Pyridine derivative and medicine
CN104262265B (zh) * 2014-07-21 2016-04-13 湖南华腾制药有限公司 一种四氢喹唑啉衍生物的制备方法
CN106083554B (zh) * 2016-06-12 2018-12-07 南京工业大学 一种一锅法制备2-乙酰基环己酮的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57203072A (en) * 1981-06-05 1982-12-13 Sankyo Co Ltd 4-anilinopyrimidine derivative, its preparation, antidepressant comprising it as active ingredient
JPS6270A (ja) * 1985-03-07 1987-01-06 Sankyo Co Ltd シクロペンタ〔ｄ〕ピリミジン誘導体
US5234936A (en) * 1991-10-24 1993-08-10 American Home Products Corporation Pyrimidocycloalkanes as a ii antagonists
TW574214B (en) 1994-06-08 2004-02-01 Pfizer Corticotropin releasing factor antagonists
TW477787B (en) 1996-08-27 2002-03-01 Pfizer Pyrido six-membered nitrogen-containing cyclic ring derivatives having corticotropin releasing factor antagonist activity and pharmaceutical composition containing same
EP0977737B1 (de) * 1997-04-22 2003-09-17 Janssen Pharmaceutica N.V. Chinolin- und chinazolin-derivate als crf antagonisten
NL1010018C2 (nl) * 1997-09-09 1999-03-10 Duphar Int Res Chinoline en chinazoline derivaten met corticotropine releasing factor (CRF) antagonistische werking.
US6432989B1 (en) 1999-08-27 2002-08-13 Pfizer Inc Use of CRF antagonists to treat circadian rhythm disorders
PL366934A1 (en) * 2001-04-30 2005-02-07 Glaxo Group Limited Fused pyrimidines as antagonists of the corticotropin releasing factor (crf)

Also Published As

Publication number Publication date
US7223767B2 (en) 2007-05-29
EP1656354A1 (de) 2006-05-17
JP2007501821A (ja) 2007-02-01
CN100398524C (zh) 2008-07-02
US20050038052A1 (en) 2005-02-17
CA2534785A1 (en) 2005-02-17
ATE374190T1 (de) 2007-10-15
CN1835931A (zh) 2006-09-20
WO2005014557A1 (en) 2005-02-17
DE602004009200T2 (de) 2008-07-10
ES2293317T3 (es) 2008-03-16
EP1656354B1 (de) 2007-09-26

Similar Documents

Publication Publication Date Title
DE602004009200D1 (de) Tetrahydrochinazolinderivate als cfr-antagonisten
DE602004008098D1 (de) Substituierte 2h-ä1,2,4ütriazoloä4,3-aüpyrazine als gsk-3-inhibitoren
EA200301073A1 (ru) N-(2-арилэтил)бензиламины в качестве антагонистов 5-ht-рецептора
DE60210944D1 (de) N-substituierte heterocyclische nichtaryl-nmda/nr2b-antagonisten
CY1113395T1 (el) Σταθερη φαρμακευτικη συνθεση που περιεχει πυριμιδινη-σουλφαμιδη
ATE469892T1 (de) Substituierte 1h-dihydropyrazole, ihre herstellung und verwendung
DK1606242T3 (da) Azidfri fremgangsmåde til fremstilling af 1,2-diaminoforbindelser
ATE409179T1 (de) Tetralin- und indanderivate und deren anwendungen als 5-ht-antagonisten
NO20054135L (no) Kipolinon/benzoksazin derivater og anvendelser derav
ATE413388T1 (de) Muskarin antagonisten
DE602005007064D1 (de) Chromanderivate und ihre verwendung als liganden des 5-ht-rezeptors
PL374019A1 (en) Benzoxazine derivatives as 5-ht6 modulators and uses thereof
MY136824A (en) Substituted benzoxazinones and uses thereof
DK1643984T3 (da) Anvendelse af parthenolidderivater som antileukæmiske og cytotoksske midler
DE60313350D1 (de) Pyrimidin-2,4-dion-derivate als matrix-metalloproteinase-hemmer
MY138826A (en) 2,7-substituted indoles
BRPI0409376A (pt) derivados de indeno como agentes farmacêuticos
MY138466A (en) Aminoalkoxyndoles as 5-ht6-receptor ligands for the treatment of cns-disorders
TW200738697A (en) Benzimidazole derivatives as 5-HT6,5-HT24
EP1845780A4 (de) Verwendung von methylphenidat-derivaten
BR0318521A (pt) arilindenopiridinas e arilindenopirimidinas e métodos terapêuticos e profiláticos relacionados
WO2004067703A3 (en) 5ht7 antagonists and inverse agonists
ATE465151T1 (de) 4-aryloxy-chinolin-derivate als 5-ht6-modulatoren
ATE419242T1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
ATE406363T1 (de) Methylindole und methylpyrrolopyridine als alpha- 1-adrenerge agonisten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition